(firstQuint)Nefazodone in the Treatment of Social Phobia.

 The purpose of this study is to examine the efficacy of the 5HT2 receptor antagonist nefazadone in SAD, and to explore regional cerebral blood flow in patients with SAD when confronted with a personal phobic stimulus, using positron emission tomography (PET).

 Changes in cerebral blood flow were correlated with self-rated anxiety measures.

.

 Nefazodone in the Treatment of Social Phobia@highlight

The purpose of this study is to determine the effectiveness of nefazadone in patients with social anxiety disorder (SAD).

